(2E)-4-Oxo-4-{(pyridin-4-ylmethyl)[2-(pyrrolidin-1-ylsulfonyl)ethyl]amino}but-2-enoic acid
- $95 - $349
- Product name: (2E)-4-Oxo-4-{(pyridin-4-ylmethyl)[2-(pyrrolidin-1-ylsulfonyl)ethyl]amino}but-2-enoic acid
- CAS: 929867-15-2
- MF: C16H21N3O5S
- MW: 367.42
- EINECS:
- MDL Number:MFCD08746920
- Synonyms:(2E)-4-Oxo-4-{(pyridin-4-ylmethyl)[2-(pyrrolidin-1-ylsulfonyl)ethyl]amino}but-2-enoic acid;(E)-4-keto-4-(4-pyridylmethyl-(2-pyrrolidin-1-ylsulfonylethyl)amino)but-2-enoic acid;(E)-4-oxo-4-(4-pyridylmethyl-(2-1-pyrrolidinylsulfonylethyl)amino)but-2-enoic acid;(E)-4-oxo-4-(4-pyridylmethyl-(2-pyrrolidin-1-ylsulfonylethyl)amino)but-2-enoic acid;(E)-4-oxo-4-(pyridin-4-ylmethyl-(2-pyrrolidin-1-ylsulfonylethyl)amino)but-2-enoic acid;2-Butenoic acid, 4-oxo-4-[(4-pyridinylmethyl)[2-(1-pyrrolidinylsulfonyl)ethyl]amino]-
2 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 5g
- ManufacturerCrysdot
- Product numberCD11011155
- Product description4-Oxo-4-((pyridin-4-ylmethyl)(2-(pyrrolidin-1-ylsulfonyl)ethyl)amino)but-2-enoicacid 97%
- Packaging5g
- Price$349
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number065305
- Product description(2E)-4-Oxo-4-{(pyridin-4-ylmethyl)[2-(pyrrolidin-1-ylsulfonyl)ethyl]amino}but-2-enoic acid
- Packaging500mg
- Price$95
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11011155 | 4-Oxo-4-((pyridin-4-ylmethyl)(2-(pyrrolidin-1-ylsulfonyl)ethyl)amino)but-2-enoicacid 97% | 5g | $349 | 2021-12-16 | Buy |
Matrix Scientific | 065305 | (2E)-4-Oxo-4-{(pyridin-4-ylmethyl)[2-(pyrrolidin-1-ylsulfonyl)ethyl]amino}but-2-enoic acid | 500mg | $95 | 2021-12-16 | Buy |
Properties
Boiling point :659.3±65.0 °C(Predicted)
Density :1.40±0.1 g/cm3(Predicted)
pka :3.54±0.10(Predicted)
Density :1.40±0.1 g/cm3(Predicted)
pka :3.54±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|